ST has made several key recommendations to the Federal Government’s National Medicines Policy Review, to improve timely and affordable access to specialist medicines. Click to read full submission.
- Welcome to Specialised Therapeutics
-
SE Asia (HQ)
+65 3158 9910
-
Australia
1300 798 820
-
New Zealand
+64 9801 0299
SidebarCategory - Specialised Therapeutics - Page 2
October 12, 2022
September 16, 2022
New Treatment for Rare Cancer Cholangiocarcinoma Approved in Australia
Melbourne, Australia 15 September 2022: A NEW targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Australia.
September 5, 2022
Meet the Specialist: Dr Toh Chee Keong
Low-dose thoracic CT screening of chronic and former smokers aged over 50 would help to detect early lung cancers and save lives, according to Singapore lung cancer expert Dr Toh Chee Keong. The leading oncologist says he would like to see a subsidised program for early detection – much like the mammogram screening program for breast cancer.
August 19, 2022
When ‘one in a million’ is not uncommon: Dr Jason Chan discusses rare cancers in Singapore
Rare cancers in Singapore are not so rare, according to medical oncologist Dr Jason Chan, who specialises in treating patients with less common oncologic variations. He says up to 7000 Singapore cancer patients are diagnosed every year with one of about 200 rare cancer variations – which means there are fewer treatment options and scarce information.
August 11, 2022
Meet the Singapore Specialist: Medical Oncologist Dr Lynette Ngo
While 1 in 13 women Singaporean women will be diagnosed with breast cancer in their lifetime – the highest incidence in South-East Asia – senior oncologist Dr Lynette Ngo wants her patients to know that five-year survival rates “are better than they have ever been”, even for those with advanced cancers.
July 13, 2022
New Therapy for Rare Gastrointestinal Stromal Tumours Accepted in Singapore for Regulatory Evaluation
Singapore, 12 July 2022: A novel therapy to treat rare gastrointestinal stromal tumours (GIST) has been accepted for evaluation by Singapore’s Health Sciences Authority.
July 8, 2022
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in the Philippines
Singapore, 8 July 2022: A NEW drug shown to significantly reduce the risk of cancer recurrence or death in an aggressive form of breast cancer is now approved by the Food and Drug Administration of the Philippines. The drug, NERLYNX (neratinib) is an oral medication taken daily for 12 months by women who have been diagnosed with early-stage HER2-positive (HER2+) breast cancer and who have received prior trastuzumab-based therapy.
July 5, 2022
Specialised Therapeutics Appoints New Logistics Partner
Singapore, 4 July 2022: International biopharmaceutical company Specialised Therapeutics (ST) has struck an important agreement with highly recognised logistics partner Healthcare Logistics (HCL) to store and distribute its growing portfolio of specialist healthcare products in Australia.
March 29, 2022
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Now Available in Malaysia
Singapore, 29 March 2022: A NEW drug shown to significantly reduce the risk of cancer recurrence or death in an aggressive form of breast cancer is now available in Malaysia. The drug, NERLYNX® (neratinib) is an oral medication taken for 12 months by women who have been diagnosed with early stage HER2-positive (HER2+) breast cancer and who have received prior trastuzumab-based therapy.
March 16, 2022
Meet the Singapore Specialist: Medical Oncologist Dr Tan Yew Oo
He was one of Singapore’s first medical oncologists and now in his late seventies, Dr Tan Yew Oo is one of the oldest practising oncologists, seeing cancer patients daily and striving to make a difference.